Boston, MA
Website: Beth Israel Deaconess Medical Center
Boston, MA
Website: Beth Israel Deaconess Medical Center
Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Status: Open to Accrual
Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma
Status: Closed to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter